Trial status: Active, not recruiting Clinical Trials Identifier: NCT06914895 Trial Name: A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight (SURPASS-T1D-1) Diabetes Type: Type 1 diabetes Trial Sponsor: Eli Lilly Why is this study important
DTSQ has been specifically designed to measure satisfaction with diabetes treatment regimens (23)
Davison BA, Harrison SA, Cotter G et al (2020) Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials
As a point of reference, the International Peptide Society notes that epithalon administered intranasally would require two to three times the injectable dosage to achieve comparable bioavailability, and thus effect
This makes it ideal for athletes, busy professionals, or anyone who experiences frequent tiredness
Un entorno cmodo y relajante puede mejorar los efectos del DSIP